Recombinant human interleukin-1 receptor antagonist in severe traumatic brain injury: a phase II randomized control trial - Helmy, A; Guilfoyle, M R; Carpenter, K L; Pickard, J D; Menon, D K; Hutchinson, P J (J Cereb Blood Flow Metab, 2014)